Oxycodone/Oxymorphone Urine Immunoassay Reagent - Detection of Oxycontin Abuse in Urine

This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR 12.6, Streamlined Procedures for Evaluation and Solicitation of Commercial Items and FAR 16.503 Requirements Contracts, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. It is the contractor’s responsibility to be familiar with the applicable FAR and DFARS clauses and provisions. The FAR and DFARS clauses may be accessed in full text at these addresses: https://www.acquisition.gov/FAR/ and www.acq.osd.mil/dpap/dfars/index.htm.



The NAICS code is 325413, with a business size standard of 500 employees.





This Request for Proposal (RFP) is on behalf of the Department of Defense (DOD) Drug Testing Program Laboratories. This requirement is for Oxycodone/Oxymorphone urine immunoassay reagent kits for the detection of Oxycontin abuse in urine.



Please see the attached document for the combined synopsis/solicitation N62645-12-R-0058.